PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION BETWEEN LUMIRACOXIB AND FLUVASTATIN

被引:0
|
作者
Anbu, Jayaraman [1 ]
Anjana, Ashwini [1 ]
Roosewelt, C. [1 ]
Rao, G. Srinivasa [1 ]
Sathish, R. [2 ]
机构
[1] VISTAS Vels Univ, Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Chennai 600117, Tamil Nadu, India
[2] NIS, Dept Toxicol, Chennai 600044, Tamil Nadu, India
关键词
Lumiracoxib; Fluvastatin; COX-2; inhibitors; Rheumatoid arthritis; Hypolipidemic;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The present study was carried out to investigate the pharmacokinetics and pharmacodynamic interaction between Lumiracoxib (20mg/kg p.o.) and Fluvastatin (5mg/kg p.o.) alone and their combination in rats by open labeled parallel study design. The animals were maintained on a standard laboratory conditions and were divided into 3 and 6 groups for Pharmacokinetic and Pharmacodynamic studies respectively.
引用
收藏
页码:P42 / P50
页数:9
相关论文
共 50 条
  • [1] Pharmacokinetic interaction between fluvastatin and diltiazem in rats
    Choi, Jun-Shik
    Piao, Yong-Ji
    Han, Hyo-Kyung
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2006, 27 (09) : 437 - 441
  • [2] PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION BETWEEN FUROSEMIDE AND METOLAZONE
    MARONE, C
    MUGGLI, F
    FREY, FJ
    KIDNEY INTERNATIONAL, 1985, 28 (03) : 596 - 596
  • [3] THE PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION BETWEEN PROPAFENONE AND LIDOCAINE
    UJHELYI, MR
    ORANGERS, EA
    FAN, C
    KLUGER, J
    PHARAND, C
    CHOW, MSS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (01) : 38 - 48
  • [4] Pharmacodynamic and pharmacokinetic interaction between fenofibrate and ezetimibe
    Kosoglou, T
    Statkevich, P
    Fruchart, JC
    Pember, LJC
    Reyderman, L
    Cutler, DL
    Guillaume, M
    Maxwell, SE
    Veltri, EP
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (08) : 1197 - 1207
  • [5] PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION BETWEEN CARBARYL AND CIMETIDINE
    MAY, DG
    WARD, SA
    NAUKAM, RJ
    KAMBAM, JR
    HEATH, AJ
    BRANCH, RA
    VETERINARY AND HUMAN TOXICOLOGY, 1988, 30 (04) : 363 - 363
  • [6] The pharmacokinetic and pharmacodynamic interaction between zileuton and terfenadine
    Awni, WM
    Cavanaugh, JH
    Leese, P
    Kasier, J
    Cao, GL
    Locke, CS
    Dube, LM
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 52 (01) : 49 - 54
  • [7] NO PHARMACOKINETIC OR PHARMACODYNAMIC INTERACTION BETWEEN RIVASTATIN AND WARFARIN
    SCHALL, R
    MULLER, FO
    HUNDT, HKL
    RITTER, W
    DUURSEMA, L
    GROENEWOUD, G
    MIDDLE, MV
    JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (03): : 306 - 313
  • [8] PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION BETWEEN NISOLDIPINE AND PROPRANOLOL
    LEVINE, MAH
    OGILVIE, RI
    LEENEN, FHH
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1986, 9 (03): : A17 - A17
  • [9] The pharmacokinetic and pharmacodynamic interaction between zileuton and terfenadine
    Walid M. Awni
    John H. Cavanaugh
    Philip Leese
    Jeanette Kasier
    Guoliang Cao
    Charles S. Locke
    Louise M. Dube
    European Journal of Clinical Pharmacology, 1997, 52 : 49 - 54
  • [10] The pharmacokinetic/pharmacodynamic interaction between zileuton and terfenadine
    Awni, WM
    Cao, G
    Kasier, JF
    Locke, CS
    Machinist, JM
    Dube, LM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PII61 - PII61